Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
New drug aficamten aims to ease heart blockage in kids
Disease control Recruiting nowThis study tests a medication called aficamten in children aged 12 to 18 with a heart condition that makes the heart muscle too thick and blocks blood flow. The goal is to see if the drug can reduce the pressure gradient across the heart's main pumping chamber and improve symptom…
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
New drug aims to cut heart failure hospitalizations and deaths
Disease control Recruiting nowThis study tests an investigational drug called omecamtiv mecarbil in 1800 adults with severe heart failure and a very weak heart pump. The goal is to see if the drug can lower the risk of serious events like hospitalization, need for a heart pump or transplant, stroke, or death.…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 17, 2026 03:17 UTC
-
New pill aims to ease heart failure symptoms in 60-patient trial
Symptom relief Recruiting nowThis study tests an experimental drug called CK-4021586 in 60 adults with a type of heart failure where the heart pumps normally but is too stiff (HFpEF). The goal is to see if the drug is safe and can improve symptoms and heart function. Participants will receive either the drug…
Phase: PHASE2 • Sponsor: Cytokinetics • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC